Tower Research Capital (TRC)’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.7K | Buy |
9,698
+1,796
| +23% | +$6.05K | ﹤0.01% | 3335 |
|
|
2025
Q1 | $30.5K | Buy |
7,902
+6,141
| +349% | +$23.7K | ﹤0.01% | 2596 |
|
|
2024
Q4 | $10.9K | Buy |
1,761
+56
| +3% | +$346 | ﹤0.01% | 3770 |
|
|
2024
Q3 | $9.17K | Sell |
1,705
-4,337
| -72% | -$23.3K | ﹤0.01% | 3896 |
|
|
2024
Q2 | $20.2K | Buy |
6,042
+3,365
| +126% | +$11.3K | ﹤0.01% | 3760 |
|
|
2024
Q1 | $10.8K | Sell |
2,677
-18,826
| -88% | -$75.9K | ﹤0.01% | 3650 |
|
|
2023
Q4 | $57K | Buy |
21,503
+4,983
| +30% | +$13.2K | ﹤0.01% | 3044 |
|
|
2023
Q3 | $39K | Buy |
16,520
+11,220
| +212% | +$26.5K | ﹤0.01% | 2769 |
|
|
2023
Q2 | $33.4K | Buy |
5,300
+3,201
| +153% | +$20.2K | ﹤0.01% | 2907 |
|
|
2023
Q1 | $12K | Sell |
2,099
-1,142
| -35% | -$6.53K | ﹤0.01% | 4067 |
|
|
2022
Q4 | $33K | Sell |
3,241
-5,769
| -64% | -$58.7K | ﹤0.01% | 2657 |
|
|
2022
Q3 | $151K | Buy |
9,010
+2,951
| +49% | +$49.5K | ﹤0.01% | 2185 |
|
|
2022
Q2 | $85K | Buy |
6,059
+5,669
| +1,454% | +$79.5K | ﹤0.01% | 2414 |
|
|
2022
Q1 | $6K | Sell |
390
-881
| -69% | -$13.6K | ﹤0.01% | 4868 |
|
|
2021
Q4 | $27K | Buy |
1,271
+825
| +185% | +$17.5K | ﹤0.01% | 3338 |
|
|
2021
Q3 | $7K | Sell |
446
-1,683
| -79% | -$26.4K | ﹤0.01% | 4632 |
|
|
2021
Q2 | $42K | Buy |
2,129
+1,731
| +435% | +$34.1K | ﹤0.01% | 3168 |
|
|
2021
Q1 | $12K | Buy |
+398
| New | +$12K | ﹤0.01% | 4250 |
|